78 completed, 21 unknown, 13 recruiting, 13 terminated. 38 Phase 2, 20 Phase 1, 19 Phase 3, 18 Phase 4, 12 Not applicable.
Follow Pseudomonas Infections: new trials by email Literature Review of Pseudomonas Infections trials Research Report on Pseudomonas Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa Bacteriophages GMP, saline solution (placebo) - Ventilator Associated Bacterial Pneumonia, Pseudomonas Aeruginosa Infection | Phase 3 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 184 | 2026-11-03 | 2026-09-04 |
| Early Optimization of Ceftazidime Regimen in Critical Care ceftazidime, plasma ceftazidime dosage - Infection in ICU, Sepsis | Not applicable | Not yet recruiting | Centre Hospitalier Universitaire de Saint Etienne | 128 | 2026-10-01 | 2026-09-16 |
| Microbiological Screening Of Malignant Otitis Externa Patients Presenting at Sohag University Hospitals ear swab and susceptibility testing - Malignant Otitis Externa | Recruiting | Sohag University | 40 | 2026-09-01 | 2026-08-27 | |
| MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia MP101, Antibiotics - Pneumonia - Bacterial, Pseudomonas Aeruginosa Infection | Phase 1 | Recruiting | MicrobiotiX Co., Ltd | 18 | 2026-07-25 | 2026-07-28 |
| Ceftazidime-Avibactam PK/PD and Resistance in Hematology Patients Ceftazidime-avibactam, Therapeutic Drug Monitoring (TDM) and Microbiological Surveillance - Hematologic Neoplasms, Gram-Negative Bacterial Infections | Not yet recruiting | Sizhou Feng | 60 | 2026-07-09 | 2026-07-14 | |
| First in Human Trial of CTX-187 in Healthy Volunteers and Chronically Infected Patients Placebo, CTX-187 - Bronchiectasis Adult, Bronchiectasis With Pseudomonas Aeruginosa Colonization | Phase 1 | Recruiting | Centauri Therapeutics Limited | 104 | 2026-06-16 | 2026-07-16 |
| Rapid Detection of Pseudomonas Aeruginosa in Bronchoalveolar Lavage Fluid Using Label-free Single-particle Imaging Technology and Assessment of Post-treatment Efficacy in Patients With Pseudomonas Aeruginosa Infection bronchoscopy - Rapid Detection, Pseudomonas Aeruginosa Infection | Not yet recruiting | The First Affiliated Hospital with Nanjing Medical University | 100 | 2025-09-01 | 2025-08-14 | |
| CONTinuous Infusion Versus Intermittent Dosing of ceftaZidime/AVIbactam in Critically Ill Patients Continuos ceftazidime/avibactam infusion, Intermitent dosing as per SMPC - Severe Infection | Phase 4 | Not yet recruiting | Ivan Šitum, MD | 140 | 2025-05-01 | 2025-04-22 |
| Monotherapy vs Combination Therapy for Bone Infections Caused by Pseudomonas Aeruginosa Osteomyelitis, Pseudomonas Infections | Recruiting | Centre Hospitalier de Saint-Denis | 300 | 2025-04-11 | 2025-07-09 | |
| Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa Pseudomonas Infections, Pseudomonas Aeruginosa | Recruiting | Centre Hospitalier Régional d'Orléans | 600 | 2025-03-11 | 2026-04-30 | |
| Remote Sputum Collection in Cystic Fibrosis Cystic Fibrosis, Infections | Recruiting | University of Pennsylvania | 150 | 2025-01-15 | 2026-08-19 | |
| Pathobiomes in Gut of Critically Ill Patients P. aeruginosa using in vitro and in vivo assays - Pseudomonas Aeruginosa | Recruiting | University of Chicago | 100 | 2024-12-19 | 2026-02-02 | |
| Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II) No Intervention: Observational Cohort - Bronchiectasis Adult | Recruiting | Shanghai Pulmonary Hospital, Shanghai, China | 364 | 2024-10-16 | 2025-04-01 | |
| PMT for MDRO Decolonization PMT - Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections | Phase 2 | Completed | University of Pennsylvania | 32 | 2024-08-19 | 2026-09-24 |
| Screening of Multidrug Resistant Bacteria, and the Clinical Implication for the Patient (exposure of) MDR carriage - Multi-antibiotic Resistance | Unknown | Region Skane | 10000 | 2024-06-01 | 2024-04-17 | |
| Development and Validation of (Bio)Sensors for the Identification of Pathogens Nanobiotechnology platforms - Infections, Infection, Bacterial | Completed | University of Bologna | 149 | 2024-05-30 | 2025-12-10 | |
| Further MT for Antibiotic-Resistant Bacterial Colonization Microbiome Therapeutic, Placebo - Intestinal Multi-drug Resistant Organism Colonization | Phase 2 | Recruiting | Emory University | 40 | 2024-04-25 | 2026-05-06 |
| A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection RSP-1502, Tobramycin inhalation solution - Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic | Phase 1 / Phase 2 | Completed | Respirion Pharmaceuticals Pty Ltd | 71 | 2024-04-01 | 2026-06-25 |
| Phenotypic and Genotypic Characteristics of Pseudomonas Aeruginosa Isolates in Sohag University Hospitals Pseudomonas Aeruginosa Infection | Unknown | Sohag University | 100 | 2024-04-01 | 2024-05-20 | |
| Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial Intravenous Antibiotics, Oral Antibiotics - Gram-negative Bacteremia | Not applicable | Recruiting | Johns Hopkins University | 1030 | 2024-02-22 | 2026-03-11 |
Showing 20 of 136. Sign in to see all of them.
Cystic Fibrosis (56) · Bronchiectasis (12) · Pneumonia (11) · Infections (10) · Staphylococcal Infections (9) · Pneumonia, Ventilator-Associated (7) · Sepsis (7) · Bacteremia (6) · Bacterial Infections (5) · Lung Diseases (5) · Gram-Negative Bacterial Infections (4) · Respiratory Tract Infections (4) · Acinetobacter Infections (3) · COVID-19 (3)
Bacterial Infections and Mycoses (136) · Gram-Negative Bacterial Infections (132) · Bacterial Infections (131) · Infections (126) · Respiratory Tract Diseases (85) · Lung Diseases (71) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (56) · Digestive System Diseases (56) · Genetic Diseases, Inborn (56) · Infant, Newborn, Diseases (56) · Pancreatic Diseases (56) · Pathological Conditions, Signs and Symptoms (35) · Pathologic Processes (34) · Disease Attributes (20) · Respiratory Tract Infections (19)
Inhalation (8) · Tobramycin (6) · Aztreonam (5) · Ceftazidime (5) · Ciprofloxacin (5) · ceftolozane, tazobactam drug combination (5) · Sodium Chloride (4) · Anti-Bacterial Agents (3) · Azithromycin (3) · Meropenem (3) · Piperacillin, Tazobactam Drug Combination (3) · Amikacin (2) · Phage Therapy (2) · Saline Solution (2) · Standard of Care (2)
Gilead Sciences (11) · Novartis Pharmaceuticals (4) · Sohag University (4) · Assistance Publique - Hôpitaux de Paris (3) · Humanigen, Inc. (3) · National Heart, Lung, and Blood Institute (NHLBI) (3) · Aradigm Corporation (2) · Aridis Pharmaceuticals, Inc. (2) · Armata Pharmaceuticals, Inc. (2) · Bayer (2) · Emory University (2) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (2) · Insmed Incorporated (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Polyphor Ltd. (2)
United States (55) · France (23) · Spain (17) · Germany (15) · United Kingdom (11) · Italy (10) · Canada (9) · Australia (8) · Belgium (8) · China (7) · Poland (7) · Austria (6) · Hungary (6) · Netherlands (6) · Greece (5)
Bruce Montgomery, MD (2) · Gina Eagle, MD (2) · Jochen Mainz, M.D. (2) · Joel Moss, M.D. (2) · Mark Bresnik, MD (2) · Adam Hill, MD PhD (1) · Adam T Hill, MBChB MD (1) · Alan H Cohen, MD (1) · Alexander Mangushlo, MD (1) · Alexander Shvets, MD (1) · Alexandre Prehn Zavascki (1) · Andrew Burke, MBBS (1)
PMID 26709158, PMID 15269195, PMID 17121631, PMID 18199038, PMID 18444865, PMID 18625681, PMID 18658109, PMID 19374579, PMID 19420195, PMID 19447923, PMID 19470318, PMID 19635928, PMID 20175247, PMID 20463812, PMID 20597081, PMID 21441078, PMID 21793988, PMID 21995648, PMID 22252816, PMID 22554417, PMID 22752516, PMID 22985692, PMID 23394211, PMID 23616495, PMID 23697744, PMID 23776701, PMID 24019259, PMID 24191943, PMID 24514083, PMID 24596456, PMID 25091537, PMID 25430979, PMID 25453872, PMID 25461655, PMID 26259799, PMID 26416780, PMID 26607424, PMID 26626719, PMID 27418577, PMID 27550351, PMID 28114979, PMID 28554732, PMID 28614995, PMID 28889110, PMID 29038277, PMID 29890086, PMID 30545985, PMID 30658914, PMID 31238116, PMID 31451351
2018 (2), 2008 (1), 2023 (1), 2UM1AI104681-08 (1), R01DK034108 (1), R01GM062344 (1), R01HD097692 (1), U01HL114589 (1), U01HL114623 (1), U54CK000601 (1)